innovation
Denmark's Frederiksen Says She and Greenland's Nielsen Had Constructive Meeting With Rubio
Capgemini CEO Dismisses Calls for Full European Tech Autonomy
Safran Cautious Over Stepping Into Airbus Engine Dispute With Pratt
FinanceChina's Great Wall Motor Restarts Its European Grand Tour With Hybrids, Gas-Powered Cars
China Holds Roundtable Meeting With German Companies
Date: February 13, 2026
BEIJING, Feb 13 (Reuters) - China's Ministry of Commerce said on Friday that it held a meeting with representatives from 60 German companies including BASF, BMW Group and Bayer on Thursday, adding...
Norway's Elkem Splits From China's Bluestar With $1 Billion Silicones Deal
Date: February 13, 2026
OSLO, Feb 13 (Reuters) - Norway's Elkem said on Friday it has agreed to sell the majority of its Silicones division to its biggest owner, China's Bluestar, and that the Chinese company would cease to...
Germany's Stark Valued at More Than 1 Billion Euros in Funding Round, Says Manager Magazin
Date: February 13, 2026
FRANKFURT, Feb 13 (Reuters) - Stark Defence took on new funding from investors a few weeks ago, increasing the overall value of the German startup firm and drone maker to more than 1 billion euros ($...
France-Backed Eutelsat Reports Stronger Revenue in Starlink Push
Date: February 13, 2026
PARIS, Feb 13 (Reuters) - Eutelsat on Friday reported better-than-expected revenue, bolstered by efforts from France to advance plans for a European competitor to Elon Musk's Starlink, boosting the...
Capgemini Exceeds Revenue Target as Newly Acquired Wns Drives AI Growth
Date: February 13, 2026
Feb 13 (Reuters) - French IT services group Capgemini on Friday reported full-year revenue that beat its own target, driven by accelerating growth in the fourth quarter as its recently bought WNS unit...
Analysis-Sanofi's New CEO Needs to Fix Drug Pipeline and Navigate Trump
Date: February 13, 2026
By Bhanvi Satija and Maggie Fick LONDON, Feb 13 (Reuters) - Sanofi's incoming CEO, 65-year-old Belén Garijo, faces a major task to win over investors, accelerate the French company's stalled drug...